(Q45930975)

17 December 2017

title

Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease. (English)

1 reference

17 December 2017

non-alcoholic fatty liver

main subject

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

R Dohil

1

1 reference

17 December 2017

S Schmeltzer

2

1 reference

17 December 2017

B L Cabrera

3

1 reference

17 December 2017

T Wang

4

1 reference

17 December 2017

J Durelle

5

1 reference

17 December 2017

K B Duke

6

1 reference

17 December 2017

J B Schwimmer

7

1 reference

17 December 2017

J E Lavine

8

1 reference

17 December 2017

language of work or name

English

0 references

publication date

13 March 2011

1 reference

17 December 2017

Alimentary Pharmacology & Therapeutics

published in

1 reference

17 December 2017

volume

33

1 reference

17 December 2017

issue

9

1 reference

17 December 2017

page(s)

1036-1044

1 reference

17 December 2017

Histopathology of pediatric nonalcoholic fatty liver disease.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

The Treatment of Acetaminophen Poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Antioxidant effect of cysteamine in brain cortex of young rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Effects of cysteamine on oxidative status in cerebral cortex of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Cellular thiol pools are responsible for sequestration of cytotoxic reactive aldehydes: central role of free cysteine and cysteamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

A novel approach to enhancing cellular glutathione levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Twice-daily cysteamine bitartrate therapy for children with cystinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Long-term treatment of cystinosis in children with twice-daily cysteamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Obesity induces a phenotypic switch in adipose tissue macrophage polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Adipocytokines and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Visceral obesity and hypoadiponectinemia are significant determinants of hepatic dysfunction: An epidemiologic study of 3827 Japanese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Thiol chemistry and specificity in redox signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

Mechanism for the inhibition of transglutaminase 2 by cystamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04626.X

10.1111/J.1365-2036.2011.04626.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017